Iodoethane → 1-Ethyl-4-nitroxypiperidine fumarate

HRID 1086490ノート

反応式

HRID 1086490 の反応式
[O:1]([CH:5]1[CH2:10][CH2:9][NH:8][CH2:7][CH2:6]1)[N+:2]([O-:4])=[O:3].C(=O)([O-])[O-].[K+].[K+].[CH2:17](I)[CH3:18].[C:20]([O-:27])(=[O:26])/[CH:21]=[CH:22]/[C:23]([O-:25])=[O:24]>CC(C)=O>[C:20]([OH:27])(=[O:26])/[CH:21]=[CH:22]/[C:23]([OH:25])=[O:24].[CH2:17]([N:8]1[CH2:9][CH2:10][CH:5]([O:1][N+:2]([O-:4])=[O:3])[CH2:6][CH2:7]1)[CH3:18]

参加物

6

実験手順

6.9 g. 4-Nitroxypiperidine are dissolved in 50 ml. acetone, mixed with 13.8 g. potassium carbonate and 6.1 ml. ethyl iodide and stirred for 18 hours at ambient temperature. After filtering with suction, the filtrate is evaporated, the residue is dissolved in ethyl acetate and extracted twice with aqueous sodium chloride solution. The orgainc phase is dried with anhydrous sodium sulphate. The crude product (8.2 g.) remaining after suction filtration and evaporation is converted into the fumarate by dissolving in ethanol and adding 2.7 g. fumaric acid. After filtering off with suction, there are obtained 2.6 g. of the fumarate of the title compound, i.e. 23% of theory; m.p. 131°-134° C.

後処理

  1. filtrationAfter filtering with suction
  2. customthe filtrate is evaporated
  3. dissolutionthe residue is dissolved in ethyl acetate
  4. extractionextracted twice with aqueous sodium chloride solution
  5. dry with materialThe orgainc phase is dried with anhydrous sodium sulphate
  6. filtrationafter suction filtration and evaporation
  7. dissolutionby dissolving in ethanol
  8. additionadding 2.7 g
  9. filtrationAfter filtering off with suction, there
  10. customare obtained 2.6 g

出典と根拠

ORDレコード
ord-b2dab2d39ef8479eacbbd4585a6d4e18
出典データセット
uspto-grants-1991_07
特許番号
US05030641

反応ノート

読み込み中…